These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28334941

  • 1. RNA-protein interactions govern antiviral specificity and encapsidation of broad spectrum anti-HIV reverse transcriptase aptamers.
    Lange MJ, Nguyen PDM, Callaway MK, Johnson MC, Burke DH.
    Nucleic Acids Res; 2017 Jun 02; 45(10):6087-6097. PubMed ID: 28334941
    [Abstract] [Full Text] [Related]

  • 2. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P, Prasad VR.
    J Virol; 2002 Jul 02; 76(13):6545-57. PubMed ID: 12050367
    [Abstract] [Full Text] [Related]

  • 3. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM, Kissel JD, Thacker SJ, Michalowski D, Saran D, Ji J, Hardy RW, Rossi JJ, Burke DH.
    J Virol; 2007 May 02; 81(10):5375-84. PubMed ID: 17329328
    [Abstract] [Full Text] [Related]

  • 4. Binding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase.
    Nguyen PDM, Zheng J, Gremminger TJ, Qiu L, Zhang D, Tuske S, Lange MJ, Griffin PR, Arnold E, Chen SJ, Zou X, Heng X, Burke DH.
    Nucleic Acids Res; 2020 Mar 18; 48(5):2709-2722. PubMed ID: 31943114
    [Abstract] [Full Text] [Related]

  • 5. Aptamers that recognize drug-resistant HIV-1 reverse transcriptase.
    Li N, Wang Y, Pothukuchy A, Syrett A, Husain N, Gopalakrisha S, Kosaraju P, Ellington AD.
    Nucleic Acids Res; 2008 Dec 18; 36(21):6739-51. PubMed ID: 18948292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers.
    Kissel JD, Held DM, Hardy RW, Burke DH.
    Nucleic Acids Res; 2007 Dec 18; 35(15):5039-50. PubMed ID: 17644816
    [Abstract] [Full Text] [Related]

  • 9. Biophysical Characterization of Novel DNA Aptamers against K103N/Y181C Double Mutant HIV-1 Reverse Transcriptase.
    Ratanabunyong S, Seetaha S, Hannongbua S, Yanaka S, Yagi-Utsumi M, Kato K, Paemanee A, Choowongkomon K.
    Molecules; 2022 Jan 03; 27(1):. PubMed ID: 35011517
    [Abstract] [Full Text] [Related]

  • 10. 2'-fluoro-modified pyrimidines enhance affinity of RNA oligonucleotides to HIV-1 reverse transcriptase.
    Gruenke PR, Alam KK, Singh K, Burke DH.
    RNA; 2020 Nov 03; 26(11):1667-1679. PubMed ID: 32732393
    [Abstract] [Full Text] [Related]

  • 11. Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates.
    Ditzler MA, Bose D, Shkriabai N, Marchand B, Sarafianos SG, Kvaratskhelia M, Burke DH.
    Nucleic Acids Res; 2011 Oct 03; 39(18):8237-47. PubMed ID: 21727088
    [Abstract] [Full Text] [Related]

  • 12. Use of Capillary Electrophoresis to Study the Binding Interaction of Aptamers with Wild-Type, K103N, and Double Mutant (K103N/Y181C) HIV-1 RT : Studying the Binding Interaction of Wild-Type, K103N, and Double Mutant (K103N/Y181C) HIV-1 RT with Aptamers by Performing the Capillary Electrophoresis.
    Aeksiri N, Warakulwit C, Hannongbua S, Unajak S, Choowongkomon K.
    Appl Biochem Biotechnol; 2017 Jun 03; 182(2):546-558. PubMed ID: 27900665
    [Abstract] [Full Text] [Related]

  • 13. Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility.
    Trivedi V, Von Lindern J, Montes-Walters M, Rojo DR, Shell EJ, Parkin N, O'Brien WA, Ferguson MR.
    AIDS Res Hum Retroviruses; 2008 Oct 03; 24(10):1291-300. PubMed ID: 18844463
    [Abstract] [Full Text] [Related]

  • 14. Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing.
    Lange MJ, Sharma TK, Whatley AS, Landon LA, Tempesta MA, Johnson MC, Burke DH.
    Mol Ther; 2012 Dec 03; 20(12):2304-14. PubMed ID: 22948672
    [Abstract] [Full Text] [Related]

  • 15. Aptamer displacement identifies alternative small-molecule target sites that escape viral resistance.
    Yamazaki S, Tan L, Mayer G, Hartig JS, Song JN, Reuter S, Restle T, Laufer SD, Grohmann D, Kräusslich HG, Bajorath J, Famulok M.
    Chem Biol; 2007 Jul 03; 14(7):804-12. PubMed ID: 17656317
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure of HIV-1 reverse transcriptase bound to a novel 38-mer hairpin template-primer DNA aptamer.
    Miller MT, Tuske S, Das K, DeStefano JJ, Arnold E.
    Protein Sci; 2016 Jan 03; 25(1):46-55. PubMed ID: 26296781
    [Abstract] [Full Text] [Related]

  • 19. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN.
    J Virol; 2004 Dec 03; 78(24):13553-61. PubMed ID: 15564466
    [Abstract] [Full Text] [Related]

  • 20. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication.
    Joshi PJ, North TW, Prasad VR.
    Mol Ther; 2005 May 03; 11(5):677-86. PubMed ID: 15851006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.